March 05, 2015 3:44 PM ET

Pharmaceuticals

Company Overview of KAI Pharmaceuticals, Inc.

Executive Profile

Steven P. James

AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 8 different industries.

See Board Relationships
----

Background

Mr. Steven P. James, also known as Steve, serves as an Executive at Eli Lilly and Company. Mr. James served as the President and Founding Chief Executive Officer of Labrys Biologics, Inc. from December 2012 to July 2014. He served as the President and Chief Executive Officer of KAI Pharmaceuticals, Inc. from October 15, 2004 to July 2012. He served as Senior Vice President of Commercial Operations at Exelixis, Inc., from June 10, 2003 to September 15, 2004, where he ...

Corporate Headquarters

270 Littlefield Avenue
South San Francisco, California 94080-6924

United States

Phone: 650-244-1100
Fax: 650-244-1199

Board Members Memberships

Chief Executive Officer, President and Executive Director
Director
Director
2014-Present
Lead Independent Director and Chairman of Compensation Committee
2015-Present
Director

Education

Bachelor's Degree
Brown University
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
$15.2M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
$3.0M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KAI Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.